PRPO.US Precipio Inc

Healthcare Health Care Providers & Services USA Stocks
18.84 USD
Close of Nov 17, 2026
17.79 33.63
Market cap
USD 33.8M
P/E
-
P/B
2.67x
ROE
-15.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PRPO.US undervalued?

Graham number

The Graham number of Precipio Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Precipio Inc fundamental analysis

No fundamental analysis for Precipio Inc yet.

Precipio Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Precipio Inc

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc…

Full company profile